Inscripta, founded in 2015 by Andrew Garst, Ryan T Gill and Tanya Lipscomb, provides gene editing tools for academic and commercial customers.In 2018 Inscripta acquired Solana Biosciences, a life sciences company founded by veterans of Illumina . Expansion plans include a new office in the life sciences hub of San Diego.
Inscripta has an enzyme engineering program rather than a particular application and they aim to provide tools for their customers to create their own applications faster.To tackle the lack of access and high cost of CRISPR gene-editing enzymes Inscripta is engineering CRISPR endonucleases called MADzymes.The DNA sequence for one MADzyme, MAD7 is provided free for any R&D use without reach-through royalty rights.MAD7 is derived from the genome of Eubacterium rectale and is a codon-optimized nuclease similar to Cpf1 (Cas12a). Inscripta is also engineering novel enzymes for exclusive use by industry partners.
Timeline
Funding rounds
People
Don Masquelier
VP Engineering
Erik Warnecke
VP Finance
Kevin Ness
CEO
Michael Graige
Chief Technical Officer
Further reading
Documentaries, videos and podcasts
Companies
News
References
Company attributes
Categories
Related Topics
Contributors
- 1
Meredith Hanel
Medical Genetics PhD, following life science applications that improve the health of humans and our planet. - 2
Melanie Manipula
Helping organize knowledge. - 3
Joseph Burns
My name is Joe Burns. I love technology, sports and writing! - 4
Amy Sar
Data entry, interested in artificial Intelligence and NLP. - 5
Dushyant Soni
Researcher - 6
Carla Faraguna
Golden People and Operations. - 7
Jude Gomila
Founder and CEO of Golden, Entrepreneur. Investor in 200+ companies. Cantabrigian (Gonville and Caius). Interested in the Universe. - 8
Neelam Jhaveri
Techno Geek + Gamer + Fashionista + Sense of Humor = It's ME - 9
Erin Scherfner
loading information... - 10
Henry Ogolla
Passionate about reading and writing.